Skip to content
Late Breaking Science
  • Oncology
  • Osteoarthritis
  • Gynecology

ASCO 2019

February 11, 2019 by Jonathan

Test

Categories Uncategorized
Abstract 140: ARAMIS: Efficacy and safety of darolutamide in nonmetastatic castration-resistant prostate cancer (nmCRPC)

Recent Posts

  • Abstract 140: ARAMIS: Efficacy and safety of darolutamide in nonmetastatic castration-resistant prostate cancer (nmCRPC)
  • ASCO 2019

Recent Comments

    Archives

    • February 2019

    Categories

    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    © 2024 Late Breaking Science